Clinical Trial Update: A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action [Phase 4]

View source ↗

Summary

A Phase 4 randomized biomarker trial completed in rheumatoid arthritis evaluating therapeutic responses to a specific biologic mode of action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Medical University of Vienna | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED